Britain’s Nuffield Council on Bioethics, which examines ethical issues raised by new developments in biology and medicine, launched a consultation on March 1 on the ethics of new technologies and devices that intervene in the human brain.
The three main areas of the group’s focus are brain-computer interfaces (BCI), neurostimulation and neural stem cell therapy.
To launch a Nuffield Council on Bioethics consultation, Professor Tom Baldwin, chair of the inquiry, outlines the ethical issues raised by novel neurotechnologies that intervene in the brain. Dr Alena Buyx, Assistant Director of the Council, goes on to describe neurostimulation and neural stem cell therapy in more detail, and Professor Kevin Warwick, a member of the Working Party, discusses some of his work around brain-computer interfaces. Watch the video: